Publications by authors named "Yuta Inoki"

Article Synopsis
  • Isotonic fluids, particularly saline and balanced crystalloids, are important for hydration during pediatric kidney biopsies, but there's no clear preference between them.
  • A study at Kobe University Hospital evaluated both types of fluids in patients aged 1-19 during kidney biopsies from April 2021 to March 2023, measuring outcomes like hyponatremia and electrolyte balance.
  • Results showed no cases of hyponatremia in either group, with saline leading to higher serum chloride and lower bicarbonate levels, but these changes had minimal clinical significance.
View Article and Find Full Text PDF

Key Points: Patients with both and variants exhibited poor renal prognosis compared with those with autosomal dominant Alport syndrome. The proportion of patients with digenic Alport syndrome was 1.7% among all patients with Alport syndrome.

View Article and Find Full Text PDF

Background: In patients with steroid-resistant nephrotic syndrome (SRNS), the presence of monogenic variants influences therapeutic strategies. Large cohort studies reported the detection of monogenic variants in approximately 30% of patients with SRNS. However, these cohorts included many patients, such as those with symptomatic proteinuria, who did not meet the strict diagnostic criteria for pediatric nephrotic syndrome (NS).

View Article and Find Full Text PDF

Background: Wilms tumor 1 (WT1; NM_024426) causes Denys-Drash syndrome, Frasier syndrome, or isolated focal segmental glomerulosclerosis. Several WT1 intron variants are pathogenic; however, the pathogenicity of some variants remains undefined. Whether a candidate variant detected in a patient is pathogenic is very important for determining the therapeutic options for the patient.

View Article and Find Full Text PDF

Background: Membranoproliferative glomerulonephritis (MPGN) can be divided into immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G), which includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). These conditions result from abnormalities in different complement pathways and may lead to different prognoses. However, there are limited studies describing the respective clinical courses.

View Article and Find Full Text PDF

We present a case of nephronophthisis 13 that resulted from WDR19 variants. The patient, a nine-year-old Japanese boy, had detection of mild proteinuria during a school urine screening. Urinalysis revealed mild proteinuria without hematuria.

View Article and Find Full Text PDF

Background: Peritonitis is the leading cause of peritoneal dialysis (PD) discontinuation. However, few data concern risk factors of peritonitis development and catheter removal caused by treatment failure in pediatric patients.

Methods: This single-center, retrospective study analyzed data from pediatric patients who underwent chronic PD between March 2002 and June 2022.

View Article and Find Full Text PDF

Background: Nephrotic syndrome relapse within 6 months is a known risk factor for steroid-dependent nephrotic syndrome/frequently relapsing nephrotic syndrome (SDNS/FRNS), but the risk of early development of SDNS/FRNS and initiation of immunosuppression therapy remains unknown.

Methods: Patients with childhood-onset idiopathic nephrotic syndrome who had the first relapse within 6 months were enrolled. We analyzed the relationship between the time of the first relapse or the time of initial remission and incidence of SDNS/FRNS or initiation of immunosuppression therapy.

View Article and Find Full Text PDF

There are no clinical guidelines for performing nephrectomy in patients with autosomal recessive polycystic kidney disease (ARPKD). Few reports have described the clinical course of ARPKD diagnosed in the neonatal period in detail. Here, we report seven patients diagnosed with ARPKD and treated at our center during the neonatal period.

View Article and Find Full Text PDF

Background: Patients on peritoneal dialysis (PD) may develop PD-related complications that necessitate abdominal surgery. However, when to resume PD and how to prescribe PD fluid after surgery in pediatric patients are unknown.

Methods: Patients on PD who underwent small-incision abdominal surgery between May 2006 and October 2021 were included in this retrospective observational study.

View Article and Find Full Text PDF
Article Synopsis
  • Immunosuppressive therapies for inflammatory bowel disease (IBD) can impact how well vaccines work and their safety, making vaccination decisions crucial before starting treatment.
  • A consensus was created to help guide both physicians and patients in Japan about vaccinations for those with IBD, focusing on vaccine-preventable diseases, while excluding COVID-19 and cervical cancer.
  • The consensus addresses 19 key clinical questions across four topics, providing essential information for managing vaccination in pediatric and adult IBD patients, promoting informed decision-making in everyday medical practice.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on infection rates and risk factors for infection in children with idiopathic nephrotic syndrome (INS) over a period from 2010 to 2020, analyzing clinical data from 187 patients.
  • - A total of 84 infections were recorded among 55 patients, with pneumonia being the most frequent, and the study found that rituximab treatment was significantly linked to higher infection rates.
  • - Infections were notably more common during the state of B-cell depletion due to immunosuppressants (318 per 1000 person-years) compared to periods with normal B-cell counts, highlighting a shift in infection patterns related to medication use.
View Article and Find Full Text PDF

Background: Hypogammaglobulinemia is a major adverse effect from rituximab. However, the association between rituximab-induced hypogammaglobulinemia and infection frequency is unknown.

Methods: Patients who received rituximab for complicated nephrotic syndrome between February 2006 and October 2020 were enrolled in this retrospective observational study.

View Article and Find Full Text PDF
Article Synopsis
  • Hypogammaglobulinemia commonly occurs after rituximab treatment in patients with complicated steroid-dependent or frequently relapsing nephrotic syndrome, but the exact incidence and risk factors are not fully understood.
  • In a study of 103 patients who received rituximab, 58.4% experienced hypogammaglobulinemia at least once, with 22.3% developing persistent cases; low serum IgG levels were linked to these occurrences.
  • Significant risk factors for developing hypogammaglobulinemia included a history of steroid-resistant nephrotic syndrome and lower serum IgG levels at the time of treatment, as confirmed by logistic regression analysis.
View Article and Find Full Text PDF